Numyra

Gel · Topical

Prescription (Rx) Amide Local Anesthetic Antiarrhythmic

Uses

Numyra™ is indicated for topical analgesia as directed by a healthcare provider.

Dosage and administration

For topical use only. Apply to the affected area 3 to 4 times daily or as directed by a healthcare provider.

Contraindications

Numyra™ is contraindicated in patients with known hypersensitivity to lidocaine or any component of the formulation.

Warnings

For external use only. Not for ophthalmic use. Avoid contact with eyes. Excessive application may result in increased systemic absorption. Keep out of reach of children.

Overdosage

Excessive topical application may result in increased systemic absorption of lidocaine. In the event of overdose, discontinue use and seek medical attention.

Description

Numyra™ is a topical gel containing Lidocaine Hydrochloride 28 mg/g (2.8%).

How supplied

Numyra™ (Lidocaine Hydrochloride 28 mg/g) is supplied as a clear topical gel in a 3.5 oz (100 g) tube. NDC 85477-0312-07

Label text from the FDA structured product label by Oncora Pharma, LLC (revised Aug 27, 2026). Long sections are shortened; the complete label is on DailyMed.

Active ingredients

Numyra NDC products (1)

NDCStrength & formLabelerType
85477-312Lidocaine 28 mg/g
Gel
Oncora Pharma, LLCUNAPPROVED DRUG OTHER

Frequently asked questions

What is Numyra used for?

Numyra™ is indicated for topical analgesia as directed by a healthcare provider.

Who makes Numyra?

Numyra is listed by 1 labeler in the FDA NDC directory, including Oncora Pharma, LLC.